| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.01 |